AMSTERDAM – (BUSINESS WIRE) – presbia, a medical device company and leader in the restoration of near vision, announced today it has received registration approval from the medical device in Israel for his solution to the loss of vision by. With this approval, the microlens Flexivue, a safe, efficient, reliable and reversible for presbyopia that eliminates the dependency on reading glasses or contact lenses to see objects up close, is now available commercially in over 40 countries in Europe, Latin America and the Middle East.
"We are very pleased that our proven solution is now available in another country, as we continue to seek additional approvals around the world"
Presby will work with Dagesh eyes, its distributor of medical devices in Israel, to promote the microlens Flexivue, 3mm diameter implantable lens, the leading ophthalmologists throughout the country.
"We are currently recruiting and training top ophthalmologists throughout Israel, so they can provide the solution microlenses Flexivue their patients to seek a better alternative to reading glasses for the treatment of common, the age-related deterioration of near vision, "said Sharon Guzman, CEO of Eye Dagesh.
Over 500 patients have received Flexivue microlensing and have reported a satisfaction rate of over 90 percent, on average. Last presby 's post-market surveillance results released last month showed that 78 percent of the patients had near visual acuity between 20/16 to 20/25 nine months after receiving the implanted lens, with little or no change in their distance vision.
"We are very pleased that our proven solution is now available in another country, as we continue to seek additional approvals around the world," said Loshitzer Zohar, CEO of presby. "Israel is a nation known for its technological advancement, and we believe that the science of the microlens Flexivue will appeal to the increasing adult population in Israel who want a solution that has provided significant improvement in near vision of presbyopic patients ".
About presby 's Flexivue microlens
Presby 's Flexivue microlensing solution is to implement a lens of 3 mm, about 15 microns thick edge in the stroma of the cornea of ??the patient' s non-dominant eye. Using the tool presby 's inclusion of the property, the lens is placed in a pocket created in the cornea with a femtosecond laser. The lens may stay in place permanently, or can be easily removed and / or replaced if the progress of the patient 's presbyopia and a stronger prescription is needed. The procedure to less than 10 minutes does not require general anesthesia, and recovery of the patient 's visual only takes a couple of days. Because the solution uses microlenses Flexivue standard equipment and requires minimal additional training, the procedure requires no capital investment by the practice of the surgeon 's.
An animated video of the procedure is available in www.presbia.com.
ABOUT presbia
Presby is a leading provider of ophthalmic devices company focused on developing solutions for presbyopia, the age-related loss of ability to read or focus on close objects. Chief among these approaches is the Flexivue presby microlensing, a lens of 3 mm in diameter implanted using femtosecond laser technology. More information is available at www.presbia.com.
Note: The Flexivue presby microlenses and related medical procedures are not available in the U.S. and have not been evaluated or approved by the U.S. Food and Drug Administration
For the original article press here